Diabetes Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What is diabetes?

A

Diabetes mellitus describes a metabolic disorder of multiple aetiology characterised by chronic hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action or both

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Function of the pancreas

A
  • Exocrine -> excretes enzymes in the digestive tract that help with digestions
  • Endocrine -> creates hormones that help with metabolism. In type 1 diabetes certain parts of the pancreas are destroyed so the production of hormones -> insulin is insufficient.
    o Islets of Langerhans: the cells that are responsible for the endocrine functions are located here.
    -Two main cells responsible for producing the hormones:
    - Alpha cells ->responsible for secreting glucagon
    - Beta cells -> responsible for secreting insulin
    • Both hormones have a responsibility of the body’s metabolism
      o Normal function:
    • Increase in blood glucose -> sense by the beta cells -> secrets insulin in the blood -> lower BG -> cells take up glucose or stored in the liver therefore BG lowers -> BG low -> sensed by the alpha cells-> secretes glucagon -> glucagon BG raises going back to normal -> liver releases glucose which was stored
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What happens in type 1 diabetes?

A

Destruction of beta cells -> beta cells can’t produce insulin -> BG cannot be lowered -> imbalanced glucagon response -> raises BG more than the norm -> hyperglycaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Treatments for Type 1 diabetes

A
  • Complex & demanding treatment regimens
  • Expect patients to make adjustments
  • Regular blood glucose monitoring
  • Always insulin (sometimes + Metformin)
  • Forms of insulin
    • Animal
    • Human
    • Analogue: lab grown and modified to affect how quickly or slowly it acts

Insulin types

  - Rapid acting: reaches blood within 15 mins
  - Short-acting: quickly and lasts longer 
  - Immediate-acting
  - Intermediate acting
  - Long acting insulin

Injecting insulin

  • Need a layer of fat to be absorbed= SC injection= abdomen (rapid absorption), upper arms (not recommended
  • Change sites= if not then the insulin might be absorbed well as there is bruising and scar tissue
  • CSII - Insulin pump
  • CGM - continuous blood glucose monitors
  • Proper insulin dosing can require a complex matrix of decisions involving carbohydrate counting, correcting, physical activity, stress, awareness of hypoglycaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is type 2 diabetes?

A

Type 2 diabetes develops when the body becomes resistant to insulin or when the pancreas is unable to produce enough insulin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Presentation in type 2 diabetes

A
  • Chronic
  • May report no symptoms
  • Thirst
  • Polyuria
  • Blurred vision
  • Fatigue
  • Weight loss –hyperglycaemia therefore late sign 2º to CV event
  • No ketoacidosis (usually)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Risk factors for type 2 diabetes

A
  • Caucasian people aged over 40 years, and in people from Black Asian and minority ethnic groups - over 25 years: with one or more of the following risk factors:
  • A first degree family history of diabetes and/ or
  • Overweight/ obese/ morbidly obese with a BMI of 25kg/m² and above + a sedentary lifestyle and/ or
  • People who have ischaemic heart disease, cerebrovascular disease, peripheral vascular disease or treated hypertension
  • Women who have had gestational diabetes, who have tested normal following delivery (screen within 6 weeks of delivery and then one year post partum and then three yearly).
  • Women with polycystic ovarian syndrome and a BMI ≥30.
  • People with Impaired Fasting Glycaemia or Impaired Glucose Tolerance.
  • People with severe mental health problems.
  • People with hypertriglyceridaemia (fasting plasma triglyceride ≥2.3mmol/L) not due to alcohol excess or renal disease.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Diagnosis of diabetes type 2

A
  • WITH SYMPTOMS: only one test in the diagnostic range is required to make the diagnosis of diabetes
  • WITHOUT SYMPTOMS: at least two blood glucose tests must be performed on different days, the results of which must both be in the diabetic range

What is HbA1c?

  • Glycated haemoglobin
  • Measurement of average blood glucose over 2-3 month period
  • Used with capillary blood glucose to establish control
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Treatment and management of type 2 diabetes?

A
  • Improved diet
  • Regular exercise, healthy weight
  • Medication to control blood sugar
  • self-management through lifestyle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Chronic complication of diabetes

A
  • Damage to blood vessels then potentially nerves due to high blood glucose
  • Retinopathy – damage to retina
  • Nephropathy –loss of kidney function
  • Neuropathy – damage to nerves
  • Cardiovascular disease
  • Stroke
  • Gastroparesis – inadequate emptying of stomach, thought to be a problem with the nerves and muscles controlling the emptying of the stomach
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Screening for complication

A
  • Annual review – usually done in primary care unless being seen in secondary care
  • Bloods for HbA1c, Renal Profile, Lipids
  • Urine for microalbuminuria/protein
  • Blood pressure
  • Foot check
  • Eye screening
  • Blood glucose review
  • Medication review
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Acute complications of diabetes

Diabetic Ketoacidosis

A

Diagnosis

  • Glucose > 11mmol/L
  • Bicarbonate (HC03) <15mmol/L and/or pH <7.3
  • Ketonaemia ≥ 3mmol/L or significant ketonuria (> ++ on standard urinalysis sticks)

Signs and symptoms

  • Polyuria +/- Nocturia
  • Polydipsia
  • Weight loss
  • Tiredness
  • Urine or blood ketones
  • Vomiting
  • Abdominal Pain
  • Kussmaul Breathing
  • Drowsiness

Aims of therapy to resolve DKA

  • Restoration of circulatory volume
  • Clearance of ketones
  • Correction of electrolyte imbalance
  • Suppression of ketogenesis
  • Reduction of blood glucose
  • Precipitating factors identification
  • Prevention of recurrence
  • Education
  • INSULIN – fixed rate insulin infusion followed by variable rate once ketones cleared
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Hypoglycaemia

A
  • A blood glucose of under 4mmol/l
  • May be symptomatic or non-symptomatic
  • Hypo unawareness
Recognising symptoms
Adrenergic (relating to nerve cells):
Sweating
Palpitations
Shaking or tremor
Hunger
Neuroglycopenic (shortage of glucose to brain):
Confusion/poor co-ordination
Drowsiness
Slurred speech
Unusual/aggressive behaviour
Visual disturbances

Causes of hypoglycaemia

  • Too much oral hypoglycaemic agents such as Gliclazide
  • Increased exercise
  • Malnutrition/ not eating enough
  • Alcohol (Liver related – releases glucose into blood)
  • IM Injection sites (increases insulin absorption)

Treating hypoglycaemia
Conscious orientated and able to swallow
- 15-20 grams CHO
- 5-7 dextrosol tablets or 4-5 glucotabs
- 1 bottle of Glucojuice
- 150-200ml pure fruit juice
- 3-4 heaped teaspoons of sugar dissolved in water
- Re-measure 10-15 minutes later if still less than 4.0 mmol/l repeat (no more than 3 treatments in total)
- Follow up with Long acting CHO – if needed
Conscious but confused. Able to swallow
- 1.5-2 tubes of 40% glucose gel (Glucogel)
- Remeasure 10-15 minutes later if still less than 4.0 mmol/l repeat (no more than 3 Rx)
Unconscious, seizures or aggressive behaviour
- If IV access
- 75-100mls of 20% IV Glucose over 15 minutes.
- 150-200mls 10% IV Glucose over 15 minutes
- Glucagon 1mg IM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is GDM?

A

DM- Defined as carbohydrate intolerance resulting in hypoglycaemia of variable severity with onset or first recognition during pregnancy.

  • Usually no significant symptoms for the mother
  • Develops in 2nd or 3rd trimester
  • Related to changes in carbohydrate metabolism and increase insulin resistance
  • Found:
    - on routine/ selective screening or when investigating for i.e. large-for-dates baby, polyhydramnios, glycosuria
    - Retrospective diagnosis if IUD (intrauterine death)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Physiological changes in pregnancy

A
  • GT tolerance decreases progressively with increasing gestation
  • Anti-insulin hormones secreted by the placenta in normal pregnancy (HPL, glucagon and cortisol)
  • Approximate x2 of insulin production from 1st trimester to 3rd trimester
  • Increasing insulin requirement as pregnancy progresses
  • May reach 2-4 normal dosage
    o Rapid increase at 28-32 weeks (fetal growth)
  • The renal tubular threshold for glucose falls during pregnancy: tendency for glycosuria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Risk factors of GDM

A
  • Family history of DM in a first degree relative
  • Previous macrosomic baby (≥4.5kg)
  • Obesity (BMI>30kg/m2)
  • Ethnicity (South Asian, Caribbean, Middle Eastern)
  • Previous GDM ***
    Offer 2 h 75 g OGTT at 24-28w (NICE, 2019)
  • Persistent glycosuria (2+ on 1 occasion or 1+ or above on 2 or more occasions)
  • PCOS: insulin resistant background
  • Previous stillbirth (? Undiagnosed GDM)
17
Q

Effects of pregnancy on diabetes

A
  • Rapid increase insulin requirement especially between 28-32 weeks of gestation.
  • N&V- makes the glycaemic control difficult
  • More frequent hypoglycaemia
  • deterioration of pre-existing neuropathy
  • Deterioration of pre-existing diabetic nephropathy (reduced creatinine clearance and increased proteinuria
  • increased risk of diabetic ketoacidosis
18
Q

Effects of pre-existing diabetes on pregnancy

A
  • increase risk of miscarriage
  • increase risk of preeclampsia
  • increase risk of infection
  • increased risk of IOL and intrapartum interventions
  • obstructed labour
  • C/S increase
  • psychosocial impacts
19
Q

Fetal effects of diabetes

A
  • Cardiac and Neural Tube Defects (very rare sacral agenesis)
  • Renal abnormalities
  • Polyhydramnios (fetal polyuria) with associated risks
  • Stillbirth
  • Birth trauma
  • Shoulder Dystocia
  • Perinatal mortality (macrosomia)
  • Preterm Delivery (IOL)
  • Neonatal hypoglycaemia (fetal hyperinsulinaemia)
  • Polycythaemia, Jaundice
  • Hyaline membrane disease or Respiratory Distress Syndrome (RDS)
  • Early separation from mother (NICU)
  • Reduced BF rates: slight delay in lactogenesis
  • Obesity
  • Diabetes later in life
20
Q

Fetal macrosomia

A
  • Birthweight over 4.5kg or >90th centile: exact definition may vary between sites
  • Often associated with polyhydramnios
    o risk of premature SROM and cord prolapse
  • Shoulder dystocia and Birth trauma
  • IUD
  • Hypoglycaemia
  • Insulin = anabolic, growth-promoting hormone
  • Babies tend to be fat, plethoric (flushed), with all organs enlarged (especially hepatomegaly)
  • More common if maternal glucose control poor
  • Increased incidence when maternal blood glucose > 7.2 mmol/l
21
Q

Preconceptual care

A
  • Reduce the risk of congenital abnormalities
  • Improve obstetric outcomes of future pregnancies
  • Positive experience
  • Optimise short and long term effects on mother and child
  • Education - impact of pregnancy on diabetes (& vice versa)
  • Good control of glucose levels before conception
  • Individualised targets agreed with clients
  • Avoid unplanned pregnancies
  • Pre-conception health care and advice
  • Lower HbA1c levels (maintain at < 48mmol/mol - 6.5%)
  • Folic acid 5mg/day before they get pregnant until 12 weeks’ gestation (Type 2!)
  • Type 1 and type 2: 75-150 mg of aspirin daily from 12 weeks until the birth of the baby (PET-MBRRACE, 2019)
  • Assess extent of retinopathy, nephropathy, hypertension, as these complications can deteriorate during pregnancy
22
Q

Diagnosis of GDM

A
  • a fasting plasma glucose level of 5.6 mmol/litre or above or
  • a 2-hour plasma glucose level of 7.8 mmol/litre or above.
  • Review with the joint diabetes and antenatal clinic within 1 week.
23
Q

Investigations of GDM

A
  • Regular glucose monitoring
  • HbA1c: will tell you if the diabetes was recently developed or if it was before
  • Renal function, LFT’s
  • Regular fetal scans (fetal growth, dopplers, AFI)
  • Baseline observations : BP
  • Other i.e. retinal checks
24
Q

Treatment of GDM

A
  • Diet and lifestyle: at least 30 minutes of exersice
  • Oral hypoglycemic agents (metformin, glibenclamide)
  • Insulin (rapid acting, long acting etc., insulin pumps)
  • What other drugs (Aspirin75mg, Folic Acid 5mg)
25
Q

Hypoglycaemic Therapy

A
  • Changes in diet and exercise. Refer all women with gestational diabetes to a dietitian.
  • Teach women with gestational diabetes about self-monitoring of blood glucose.
  • Metformin (oral agent) if targets are not met within 1–2 weeks.
    o Insulin instead of metformin if metformin is contraindicated or unacceptable.
  • Addition of insulin to the above if blood glucose targets are not met.
    o Or immediate treatment with insulin, with or without metformin, as well as changes in diet and exercise, to women with gestational diabetes who have a fasting plasma glucose level of 7.0 mmol/litre or above at diagnosis.
    o Immediate treatment with insulin, with or without metformin, as well as changes in diet and exercise, for women with gestational diabetes who have a fasting plasma glucose level of between 6.0 and 6.9 mmol/litre if there are complications such as macrosomia or hydramnios.
  • Glibenclamide (oral agent):
    o in whom blood glucose targets are not achieved with metformin but who decline insulin therapy or who cannot tolerate metformin
26
Q

Antenatal care

A

Added specialist diabetic clinic surveillance/ pathway:

  • Dietician (diet and lifestyle advice)
  • Blood sugar monitoring
  • Therapy (diet, oral, insulin)
  • Fetal surveillance (4weeklygrowthscans- cardiac scan?)
  • No indication for routine fetal monitoring prior to 38 weeks
  • Colostrum harvesting and antenatal classes
  • Discussion re mode of delivery + infant feeding
27
Q

Intrapartum care

A
  • Diabetes should not in itself be considered a contraindication to attempting vaginal birth after a previous caesarean section (consider additional risk factors).
  • Explain to pregnant women with diabetes who have an ultrasound- diagnosed macrosomic fetus about the risks and benefits of vaginal birth, induction of labour and caesarean section.
  • Terbutaline is contraindicated it will increase BG
  • Advanced neonatal resuscitation skills and equipment must be available on site, 24hrs/day
  • Under consultant care (inform diabetic team if necessary).? MLU for GCM diet controlled?
  • IV access – bloods –IV antibiotics (Instr Del or CS)?
  • EFM
  • Anticipate shoulder dystocia
  • Available paediatric support for delivery
28
Q

Blood glucose control during labour and birth

A
  • Monitor capillary plasma glucose every hour during labour and birth in women with diabetes and ensure that it is maintained between 4 and 7 mmol/litre.
  • Intravenous dextrose and insulin infusion should be considered for women with type 1 diabetes from the onset of established labour.
  • Use intravenous dextrose and insulin infusion during labour and birth for women with diabetes whose capillary plasma glucose is not maintained between 4 and 7 mmol/litre.
  • Antacids (may need to go to theatre)
  • Anaesthesia (review 3rd trimester-type of anaesthetics-increased monitoring)
  • All normal labour observations
    o Maternal vital signs
    o Fetal wellbeing
    o Vaginal loss, liquor
    o Cervical dilatation, descent/rotation of fetus
  • Reduce rate of insulin IVI after 3rd stage
    o Return to pre-pregnancy insulin dosage in puerperium
  • Tight control of blood glucose less vital in the puerperium
29
Q

Immediate postnatal care

A
  • women with insulin-treated pre-existing diabetes should reduce their insulin immediately after birth and monitor their blood glucose levels carefully to establish the appropriate dose.
  • Explain to women with insulin‑treated pre‑existing diabetes that they are at increased risk of hypoglycaemia in the postnatal period, especially when breastfeeding, and advise them to have a meal or snack available before or during feeds. ​
  • Women who have been diagnosed with gestational diabetes should discontinue blood glucose‑lowering therapy immediately after birth.
30
Q

Postnatal care

A
  • Offer lifestyle advice (including weight control, diet and exercise).
  • Offer a fasting plasma glucose test 6–13 weeks after the birth to exclude diabetes (for practical reasons this might take place at the 6-week postnatal check).
  • If a fasting plasma glucose test has not been performed by 13 weeks, offer a fasting plasma glucose test, or an HbA1c test if a fasting plasma glucose test is not possible, after 13 weeks.
  • Do not routinely offer a 75 g 2-hour OGTT.
  • Contraception
31
Q

Long-term follow up

A
  • Offer an annual HbA1c test to women who were diagnosed with gestational diabetes who have a negative postnatal test for diabetes​
  • The role of the primary care settings (follow up, contraception, life style, reminder of preconception care)
  • Long term prognosis ( 50% women with GDM will develop Type2 DM within 10 years)
32
Q

Infant feeding and medication

A
  • Colostrum harvesting (antenatally); hand expression postnatally
  • Golden hour!!! No need for separation unless clinically indicating!
  • Importance of BF short and long term (obesity, DM…)
  • Consider why women with GDM might have BF related problems (delay in lactogenesis II, obesity, interruption of initial bond if baby in NICU etc.)
  • Consider effects of formula (incl. of obesity, rates of diabetes etc.)
    Breastfeeding and medication
  • Majority of women will not be on any diabetic medication post- delivery-no concern for type 1 (insulin)
  • Women with pre-existing type 2 diabetes who are breastfeeding can resume or continue to take metformin and glibenclamide immediately after birth but should avoid other oral blood glucose-lowering agents while breastfeeding.
  • Women with diabetes who are breastfeeding should continue to avoid any medicines for the treatment of diabetes complications that were discontinued for safety reasons in the preconception period.